![](/remote/aHR0cHM6Ly9naWVjZG4uYmxvYi5jb3JlLndpbmRvd3MubmV0L2ZpbGV1cGxvYWRzL2ltYWdlLzIwMTgvMDcvY2VudHJhbF9hbWVyaWNhLWFkb2JlX3N0b2NrLWNyZWRpdC16ZXJvcGhvdG8tcmVzaXplZC5qcGc.oOJSU-p_umY.jpg?w=948&h=533&format=webp&mode=pad&anchor=middlecenter&scale=both&bgcolor=F0F1F2)
Two weeks after Canopy Growth Corp. announced an expansion into Latin America, rival cannabis grower Aphria Inc. has announced a “proposed acquisition” worth roughly $200 million that would see it acquire two companies in South America and take a sizeable stake in a Caribbean marijuana producer.
The assets—in Colombia, Argentina and Jamaica—are owned or are in the process of being acquired by Aphria’s sister company Scythian Biosciences Corp., and held by a Scythian subsidiary LATAM Holdings Inc.
In return for LATAM Holdings, Aphria will issue Scythian 15.7 million shares, “for aggregate transaction consideration of $193 million … at a deemed share price of $12.31,” according to a press release.
That equates to 6.3 per cent of Aprhia’s outstanding shares, calculated on a non-diluted basis, and would make Scythian the largest single Aphria shareholder.
Top Image: © Zerophoto | Adobe Stock
Latest from Cannabis Business Times
- Navigating Cultivation Room Design: Optimization vs. Maximization
- Verano Opens 18th Medical Cannabis Dispensary in Pennsylvania
- Hundreds Interested in Kentucky’s Medical Cannabis Licenses; Just 17 Apply So Far
- Aurora Receives Expanded Cultivation, Unique Research Licenses for German Facility
- Curaleaf Opening 2 New York Medical Dispensaries, Launching Adult-Use Sales at 2 Other Stores
- Ohio’s Adult-Use Licensing Process Leads CBT’s Top Stories in July
- Planet 13 Launches Lifestyles Brand Company; Signs 1st Sponsored Athlete in UFC Title Contender Chito Vera
- LeafLink Acquires Leading Cannabis Banking Platform Dama Financial